Dihydropacidamycins having an antibacterial spectrum modified from that of the natural product pacidamycins and mureidomycins have been synthesized. Synthetic dihydropacidamycins with noteworthy antibacterial activity against wild-type and resistant Escherichia coli have been identified (MIC=4-8 microg/mL). Some dihydropacidamycins are shown to have activity against multi-resistant clinical strains of Mycobacterium tuberculosis. Compounds of this class are inhibitors of the cell wall biosynthetic enzyme, MraY.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0960-894x(03)00682-6 | DOI Listing |
Publication Analysis
Top Keywords
synthetic dihydropacidamycin
4
dihydropacidamycin antibiotics
4
antibiotics modified
4
modified spectrum
4
spectrum activity
4
activity pacidamycin
4
pacidamycin class
4
class dihydropacidamycins
4
dihydropacidamycins antibacterial
4
antibacterial spectrum
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!